
SEROTYPES, GENOTYPES, AND ANTIBIOTIC SUSCEPTIBILITY PROFILES OF GROUP B STREPTOCOCCI CAUSING NEONATAL SEPSIS AND MENINGITIS BEFORE AND AFTER INTRODUCTION OF ANTIBIOTIC PROPHYLAXIS
Author(s) -
Monique A. J. M. Trijbels-Smeulders,
Jan L. L. Kimpen,
L.A.A. Kollée,
Judith M. J. E. Bakkers,
Willem J. G. Melchers,
Lodewijk Spanjaard,
W J B Wannet,
Mieke A A Hoogkamp-Korstanje
Publication year - 2006
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/01.inf.0000237821.65559.08
Subject(s) - serotype , neonatal sepsis , group b , antibiotics , meningitis , sepsis , medicine , group a , genotype , antibiotic prophylaxis , microbiology and biotechnology , neonatal infection , streptococcus agalactiae , streptococcus , biology , immunology , bacteria , pediatrics , pregnancy , genetics , gene
We studied the characteristics of strains isolated from neonates with group B streptococci sepsis and meningitis, before and after the introduction of antibiotic prophylaxis in The Netherlands. In 1999, 1 year after this introduction the serotype and genotype distribution and the susceptibility patterns of the GBS strains had not changed. Penicillins remain drugs of first choice to prevent and treat neonatal GBS disease.